首页> 外文期刊>Journal of neuroimaging >The Relationship Between Brain MR Spectroscopy and Disability in Multiple Sclerosis: 20-Year Data from the US Glatiramer Acetate Extension Study
【24h】

The Relationship Between Brain MR Spectroscopy and Disability in Multiple Sclerosis: 20-Year Data from the US Glatiramer Acetate Extension Study

机译:脑MR光谱与多发性硬化症残疾关系的关系:来自美国的Glatiramer醋酸盐延伸研究的20年数据

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND AND PURPOSE: Conventional MRI techniques do not necessarily provide information about multiple sclerosis (MS) disease pathology or progression. Nonconventional MRI techniques, including proton magnetic resonance spectroscopy (H-1-MRS), are increasingly used to improve the qualitative and quantitative specificity of MR images. This study explores potential correlations between MRI measures of disease and disability progression as measured by the Expanded Disability Status Scale (EDSS), Functional Systems (FS), and ambulation index scores in a unique cohort of MS patients treated with glatiramer acetate that has been closely monitored for over 20 years.
机译:背景和目的:常规MRI技术不一定提供有关多发性硬化(MS)疾病病理或进展的信息。 非转化MRI技术,包括质子磁共振光谱(H-1-1-MRS)越来越多地用于改善MR图像的定性和定量特异性。 本研究探讨了通过扩大的残疾状态规模(EDS),功能系统(FS),功能系统(FS),用Glatizer乙酸盐患者的独特群体,功能系统(FS),功能系统(FS)和手淫指数评分来探讨MRI疾病和残疾进展之间的相关性。 监测超过20年。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号